Sinopharm Group Co. Ltd.
SHTDY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $52 | $62 | $60 | $58 |
| - Cash | $47 | $54 | $43 | $64 |
| + Debt | $93 | $76 | $101 | $74 |
| Enterprise Value | $98 | $84 | $118 | $68 |
| Revenue | $286 | $290 | $295 | $296 |
| % Growth | -1.3% | -1.7% | -0.3% | – |
| Gross Profit | $21 | $22 | $22 | $25 |
| % Margin | 7.3% | 7.7% | 7.4% | 8.5% |
| EBITDA | $10 | $11 | $10 | $13 |
| % Margin | 3.5% | 3.7% | 3.2% | 4.6% |
| Net Income | $3 | $3 | $4 | $5 |
| % Margin | 1.2% | 1.2% | 1.3% | 1.7% |
| EPS Diluted | 5.55 | 5.35 | 5.95 | 7.95 |
| % Growth | 3.7% | -10.1% | -25.2% | – |
| Operating Cash Flow | -$34 | $53 | -$41 | $60 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$35 | $51 | -$42 | $59 |